N-(1r,4r)-(4-((5-Chloro-4-(2-(((tetrahydro-2H-pyran-4-yl)methyl)amino)thiazol-4-yl)pyridin-2-yl)amino)cyclohexyl)cyclopropanecarboxamide

ID: ALA4287306

PubChem CID: 145993367

Max Phase: Preclinical

Molecular Formula: C24H32ClN5O2S

Molecular Weight: 490.07

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(N[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4CCOCC4)n3)c(Cl)cn2)CC1)C1CC1

Standard InChI:  InChI=1S/C24H32ClN5O2S/c25-20-13-26-22(28-17-3-5-18(6-4-17)29-23(31)16-1-2-16)11-19(20)21-14-33-24(30-21)27-12-15-7-9-32-10-8-15/h11,13-18H,1-10,12H2,(H,26,28)(H,27,30)(H,29,31)/t17-,18-

Standard InChI Key:  DGELUECQJXKHPB-IYARVYRRSA-N

Molfile:  

     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
   10.5775  -20.0500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2987  -19.2607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5396  -18.5695    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.0004  -19.2607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4966  -19.9094    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.8644  -19.6337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.4740  -17.8265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7151  -18.5394    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.7497  -18.8043    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0129  -20.8764    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2414  -18.5394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7214  -19.6271    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5763  -20.8769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0100  -20.0463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2979  -21.2854    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2961  -19.6333    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2987  -17.8265    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7264  -21.2834    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   16.4740  -19.2607    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8250  -19.2607    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0659  -18.5394    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8685  -18.8087    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5873  -18.4029    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5932  -17.5816    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8826  -17.1617    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1643  -17.5694    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.1566  -18.3971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8898  -16.3367    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6078  -15.9304    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6149  -15.1054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3186  -16.3491    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   11.0310  -14.3961    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2060  -14.3889    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  4  2  0
 10 14  1  0
 13 15  1  0
  9 12  2  0
  8 17  1  0
  1  6  1  0
 11 21  1  0
 17  7  1  0
 15 10  2  0
 21 19  1  0
 14 16  2  0
  4 20  1  0
 19  2  1  0
  1 13  2  0
 20 11  1  0
 16  1  1  0
 21  7  1  0
  2  8  1  0
  4  3  1  0
 10 18  1  0
 14 12  1  0
  3  9  1  0
 12  5  1  0
 22  6  1  6
 22 23  1  0
 22 27  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 25 28  1  1
 28 29  1  0
 29 30  1  0
 29 31  2  0
 32 30  1  0
 33 32  1  0
 30 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4287306

    ---

Associated Targets(Human)

CDK9 Tchem CDK9/Cyclin K (143 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MV4-11 (7307 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 490.07Molecular Weight (Monoisotopic): 489.1965AlogP: 4.95#Rotatable Bonds: 8
Polar Surface Area: 88.17Molecular Species: NEUTRALHBA: 7HBD: 3
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.79CX LogP: 3.60CX LogD: 3.60
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.49Np Likeness Score: -1.61

References

1. Wang B, Wu J, Wu Y, Chen C, Zou F, Wang A, Wu H, Hu Z, Jiang Z, Liu Q, Wang W, Zhang Y, Liu F, Zhao M, Hu J, Huang T, Ge J, Wang L, Ren T, Wang Y, Liu J, Liu Q..  (2018)  Discovery of 4-(((4-(5-chloro-2-(((1s,4s)-4-((2-methoxyethyl)amino)cyclohexyl)amino)pyridin-4-yl)thiazol-2-yl)amino)methyl)tetrahydro-2H-pyran-4-carbonitrile (JSH-150) as a novel highly selective and potent CDK9 kinase inhibitor.,  158  [PMID:30253346] [10.1016/j.ejmech.2018.09.025]

Source